Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 4,357,028 |
|
|||||
| News | - | ||||||
| Day High | 0.00055 | Low High |
|||||
| Day Low | 0.0005 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Bioadaptives Inc (PK) | BDPT | OTCMarkets | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.0001 | -16.67% | 0.0005 | 15:02:09 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.00054 | 0.0005 | 0.00055 | 0.0006 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 17 | 4,357,028 | US$ 0.000502 | US$ 2,186 | - | 0.00025 - 0.006 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 14:40:05 | 1,000,000 | US$ 0.0005 | USD |
Bioadaptives Inc (PK) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| US$ 288.23k | 576.46M | 127.75M | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Bioadaptives (PK) News
| Date | Time | Source | News Article |
|---|---|---|---|
| 11/13/2023 | 15:06 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 10/11/2023 | 14:59 | Edgar (US Regulatory) | Form 1-A - Offering Statement [Regulation A] |
| 8/24/2023 | 13:40 | Edgar (US Regulatory) | Form 1-Z - |
| 8/11/2023 | 15:16 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BDPT Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.0006 | 0.0006 | 0.0004 | 0.0005034 | 9,718,216 | -0.0001 | -16.67% |
| 1 Month | 0.0006 | 0.00065 | 0.0004 | 0.0005411 | 33,137,324 | -0.0001 | -16.67% |
| 3 Months | 0.0009 | 0.0009 | 0.0003 | 0.0005796 | 34,198,532 | -0.0004 | -44.44% |
| 6 Months | 0.0012 | 0.0014 | 0.0003 | 0.0006414 | 32,747,047 | -0.0007 | -58.33% |
| 1 Year | 0.00065 | 0.006 | 0.00025 | 0.0012795 | 35,551,711 | -0.00015 | -23.08% |
| 3 Years | 0.0299 | 0.053 | 0.00025 | 0.0014395 | 15,560,643 | -0.0294 | -98.33% |
| 5 Years | 0.1481 | 0.198 | 0.00025 | 0.0015903 | 10,276,794 | -0.1476 | -99.66% |
Bioadaptives (PK) Description
| BioAdaptives' core business is to investigate, market and distribute natural plant, algal and mushroom based products and medical devices that improve health and wellness for humans and animals, with an emphasis on natural pain relief, anti-viral, anti-inflammatory functions and anti-aging properties. The Company's current products include dietary supplements using natural ingredients and proprietary formulations and methods of optimizing the avialability of nurtients in foods and beverages. The human products are designed to aid memory, cognition and focus, assist in sleep and fatigue reduction; provide fast pain relief and healing; and improve overall emotional and physical wellness. The science behind our human products has proven to be effective for performance enhancement and pain relief for horses and dogs as well as providing improvements in appearance. |
